ARPIM
10 articole · RSS
Christian Rodseth Named President Of Romanian Association of International Drug Manufacturers
Christian Rodseth, Managing Director at Janssen Romania, is the new president of the Romanian Association of International Drug Manufacturers (ARPIM), which brings together some of the leading players on the Romanian pharmaceutical market.
Popescu, ARPIM: Patients’ Access To Innovative Drugs Still Is 1 To 10 In Romania Vs Western Europe
The access to innovative medical drugs is still reduced, as the ratio between Romania and Western Europe remained 1 to 10, Liviu Popescu, director of external relations of the Romanian Assoc...
ARPIM: Original Drug Manufacturers Invested EUR77M In Romania In 2014
Original medical drugs manufacturers on the Romanian market pumped EUR77.1 million in Romania in 2014, and most of them invested in research and development (R&D) activities in the field of...
ARPIM Head: Shortages In Healthcare Caused By Lack Of Financing, Reckless Use Of Existing Funds
Shortages in Romania’s public healthcare sector are triggered by the lack of financing and the reckless use of existing funds, Calin Galaseanu, president of the Romanian Association of Inter...
Romanian Association of International Drug Manufacturers Names New President
The Romanian Association of International Drug Manufacturers (ARPIM) named Calin Galaseanu, head of pharmaceutical company Bristol-Myers Squibb Romania, as president of the association, repl...
ARPIM: Clawback Tax Payment To Cover Costs With Extending Compensated Medicine List
Costs entailed by the introduction of new medicines on the list of compensated drugs will be entirely covered by drug producers through the clawback tax they are obliged to pay, the Romanian...
ARPIM Names Johnson&Johnson Romania’s Head As President
Romanian Association of International Drug Producers ARPIM named the head of pharmaceutical company Johnson&Johnson Romania, Efthymios (Makis) Papataxiarchis, as president in December, inste...
ARPIM: Romania Ranks Last In EU By Costs With Medical Care, Drugs
Romania ranks last in the European Union in terms of costs with medical care and drugs, which triggers a life expectancy shorter by five years than the European average and over EUR18 billio...
Drug Makers Blast Romania's “Unsustainable” Clawback Tax
Romania’s pharmaceutical industry could lose 842 million lei (EUR195 million), which means a 30% shrinking of the market, following the implementation of the new clawback tax, according to a...